1. |
Olson JC, Wendon JA, Kramer DJ, et al. Intensive care of the patient with cirrhosis. Hepatology, 2011, 54(5):1864-1872.
|
2. |
郑树森, 徐骁. 积极推进中国肝移植的发展. 中华肝胆外科杂志, 2005, 11(7):437-439.
|
3. |
Monbaliu D, Pirenne J, Talbot D. Liver transplantation using Dona-tion after Cardiac Death donors. J Hepatol, 2012, 56(2):474-485.
|
4. |
Levesque E, Hoti E, Khalfallah M, et al. Impact of reversible cardiac arrest in the brain-dead organ donor on the outcome of adult liver transplantation. Liver Transpl, 2011, 17(10):1159-1166.
|
5. |
郑树森, 吴健. 我国活体肝移植的现状与发展趋势. 外科理论与实践, 2008, 13(4):285-287.
|
6. |
黄洁夫. 中国大陆肝移植的伦理与立法. 中华肝胆外科杂志, 2007, 45(5):292-296.
|
7. |
Timek T, Vahl CF, Bonz A, et al. Triiodothyronine reverses depressed contractile performance after excessive catecholamine stimulation. Ann Thorae Surg, 1998, 66(5):1618-1625.
|
8. |
Ranasinghe AM, Bonser RS. Endocrine changes in brain death and transplantation. Best Pract Res Clin Endocrinol Metab, 2011, 25(5):799-812.
|
9. |
Li J, Yuan J. Caspases in apoptosis and beyond. Oncogene, 2008, 27(48):6194-6206.
|
10. |
钟自彪, 叶啟发, 王彦峰, 等. 脑死亡状态下家兔肝脏质量评估新指标——线粒体醛脱氢酶. 中华肝胆外科杂志, 2013, 19(7):534-538.
|
11. |
钟自彪, 王彦峰, 李玲, 等. 缓慢间断颅内加压法家兔脑死亡模型的建立及病理生理变化. 中华肝胆外科杂志, 2013, 19(8):534-538, 622-624.
|
12. |
中华人民共和国国家科学技术委员会. 实验动物管理条例. 1988.
|
13. |
Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council. Guide for the Care and Use of Lab Animals. National Academies Press, 2010. http://www.nap.edu/catalog/12910.html.
|
14. |
Quality Standards Subconmlittee of the Amecican Academy of Neurology. Practice parameters for determining brain death in adults (Summary statement). Neurology, 1995, 45(5):1012-1014.
|
15. |
Kam PC, Ferch NI. Apoptosis:mechanisms and clinical implica-tions. Anaesthesia, 2000, 55(11):1081-1093.
|
16. |
杨连君, 曹雪涛, 于益芝. Bcl-2,bax与肿瘤细胞凋亡. 中国肿瘤生物治疗杂志, 2003, 10(3):232-234.
|
17. |
岳原亦, 张扬, 张一奇. Caspase家族与细胞凋亡. 中国医疗前沿, 2011, 6 (6):25-26.
|
18. |
Li J, Yuan J. Caspases in apoptosis and beyond. Oncogene, 2008, 27(48):6194-6206.
|
19. |
Salvesen GS, Ashkenazi A. Snapshot:caspases. Cell, 2011, 147(2):476-476.
|
20. |
Ye H, Wang DP, Zhang CZ, et al. Pathological characteristics of liver allografts from donation after brain death followed by cardiac death in pigs. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(5):687-691.
|
21. |
Churchill EN, Disatnik MH, Mochy-Rosen D. Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2. J Mol Cell Cardiol, 2009, 46(2):278-284.
|
22. |
Sun L, Ferreira JC, Mochly-Rosen D. ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance. Sci Transl Med, 2011, 3:(107):107-111.
|
23. |
Li SY, Gomelsky M, Duan J, et al. Overexpression of aldehyde dehydrogenase-2 (ALDH2) transgene prevents acetaldehyde-induced cell injury in human umbilical vein endothelial cells:role of ERK and p38 mitogen-activated protein kinase. J Biol Chem, 2004, 279(12):11244-11252.
|
24. |
Guo R, Zhong L, Ren J, et al. Overexpression of ALDH2 attenuates chronic alcohol exposure-induced apoptosis, change in Akt and Pim signaling in liver. Clin Exp Pharmacol Physiol, 2009, 36(5-6):463-468.
|
25. |
Chen T, Cui J, Liang Y, et al. Identification of human liver mitochon-drial aldehyde dehydrogenase as a potential target for microcystin-LR. Toxicology, 2006, 220(1):71-80.
|
26. |
Xu D, Guthrie JR, Mabry S, et al. Mitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K-Akt pathways in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol, 2006, 291(5):L966-L975.
|
27. |
Lin MH, Yen JH, Wang CY, et al. Lipid peroxidation end product 4-hydroxy-trans-2-nonenal triggers unfolded protein response and heme oxygenase-1 expression in PC12 cells:Roles of ROS and MAPK pathways. Toxicology, 2014, 315:24-37.
|
28. |
Lang XE, Wang X, Zhang KR, et al. Isoflurane preconditioning confers cardioprotection by activation of ALDH2. PLoS One, 2013, 8(2):e52469.
|